Case Details
- Citation: [2020] SGHC 268
- Title: BLUESTONE CORPORATION PTE LTD v PHANG CHER CHOON & 2 Ors
- Court: High Court of the Republic of Singapore
- Date: 4 December 2020
- Judges: Mavis Chionh Sze Chyi JC
- Suit Nos: 793 of 2018; 794 of 2018
- Plaintiff/Applicant: Bluestone Corporation Pte Ltd (“Corporation”)
- Defendants/Respondents: Phang Cher Choon; Bluestone Healthcare Sdn Bhd; Lim Hooi Loo
- Procedural posture: Trial on liability and damages (not bifurcated); claims dismissed at trial; reasons provided on appeal
- Legal areas (as reflected in the judgment headings): Breach of confidence; employment contract (breach/termination without notice); equity (acquiescence, limitation, fiduciary duties, knowing assistance/receipt); tort (confidence, conspiracy to defraud, passing off)
- Statutes referenced: Not specified in the provided extract (the judgment headings indicate, at minimum, reference to s 391 of the Companies Act)
- Cases cited: [2020] SGHC 268 (as provided in metadata)
- Judgment length: 153 pages; 44,927 words
Summary
Bluestone Corporation Pte Ltd brought two related suits against its former director, Phang Cher Choon, and against a Malaysian company, Bluestone Healthcare Sdn Bhd (“Healthcare”), together with an employee, Lim Hooi Loo (“Hooi Loo”). The core of the Corporation’s case was that Phang breached fiduciary duties owed as a director by setting up and operating Healthcare in competition with the Corporation, and by allegedly diverting business opportunities and/or business to Healthcare. The Corporation further alleged that Hooi Loo breached her employment contract, and that all three defendants engaged in a conspiracy to defraud the Corporation. In addition, the Corporation advanced claims in tort and equity, including passing off and “knowing assistance”/receipt in relation to alleged misuse of confidential information and business goodwill.
After a full trial, the High Court dismissed the Corporation’s claims against all three defendants. The court’s reasons addressed multiple overlapping causes of action—fiduciary breach, employment breach, conspiracy, passing off, and equitable relief—while also considering defences such as acquiescence and limitation, and the evidential question of whether the Corporation could establish the alleged wrongful conduct to the required standard. The court ultimately found that the Corporation failed to prove its pleaded breaches and related allegations.
What Were the Facts of This Case?
The Corporation was a Singapore company incorporated in 1999 and described as supplying medical equipment and consumables. At all material times, Henry Tay Chai Khiang (“Henry”) was the majority shareholder and a director. Phang Cher Choon was a minority shareholder and also a director until his employment was terminated on 24 August 2018. The Corporation’s operations were divided into two divisions: medical equipment (handled by Henry) and medical consumables (handled by Phang). In addition, Henry’s parents were appointed as directors in November 2005, although Henry asserted they were intended to be “non-executive” directors.
Healthcare was incorporated in Malaysia in February 2004 and was said to deal in medical products. As at mid-2018, just before the suits were filed, Phang held 99% of the shares in Healthcare, with the remaining 1% held by Hooi Loo. Hooi Loo was also employed by the Corporation in its Malaysian branch office from 7 May 2003 until the Corporation terminated her employment on 24 August 2018. The Corporation’s pleaded narrative was that Healthcare’s establishment and growth were part of a scheme by Phang (and involving Hooi Loo) to compete with the Corporation and divert opportunities away from it.
A key factual theme was the parties’ relationship and the “ground rules” Henry and Phang allegedly agreed for managing the Corporation’s business. Henry testified that they agreed that if business opportunities in the medical and healthcare industry were made available to either of them, they would disclose and offer the opportunity to each other. If the other party did not accept, the opportunity could be pursued independently. Henry also asserted that they were free to pursue independent interests in non-related businesses. This “ground rules” framework became central to the court’s analysis of whether Phang’s conduct amounted to a breach of fiduciary duty, and whether the Corporation had consented to or acquiesced in competitive conduct.
Several business developments were highlighted. Henry claimed that in 2012, an opportunity to market and sell Sonosite machines in Malaysia arose and that he informed Phang of his intention to proceed when Phang showed no interest. Henry then set up Absolmed Sdn Bhd (“Absolmed”) to deal with the Sonosite distributorship in Malaysia until it closed around 2016 or 2017. Phang disputed that he had been informed about Henry’s plan to set up Absolmed. The Malaysian branch office of the Corporation, registered in March 2000, was also significant. Henry’s position was that the branch office was intended to explore opportunities and market the Corporation’s consumables, with enquiries channelled to the Singapore office, and with a plan to later incorporate the Malaysian operations into a fully-fledged Malaysian entity when resources and readiness permitted. Phang’s account of the objective and circumstances of the Malaysian branch office differed.
The factual matrix also included the employment and involvement of Hooi Loo and the establishment of other entities, including Prius Pte Ltd and Primuz Pte Ltd, which the Corporation alleged were connected to the competitive activities. The relationship between Henry and Phang deteriorated between 2016 and 2018, culminating in Phang’s termination on 24 August 2018. The Corporation’s claims were framed around alleged diversion of business and business opportunities to Healthcare, alleged misuse of the Malaysian branch office premises, alleged self-dealing, and alleged breaches of fiduciary duties and employment obligations.
What Were the Key Legal Issues?
First, the court had to determine whether Phang breached fiduciary duties owed to the Corporation in setting up and operating Healthcare. This required the court to identify the nature and scope of Phang’s fiduciary relationship as a director, the content of the duties allegedly breached (including duties relating to conflict of interest, loyalty, and avoidance of self-dealing), and whether the Corporation could establish that Phang’s conduct fell within those breaches on the evidence.
Second, the court had to consider whether Phang breached fiduciary duties in specific factual contexts: (a) having Healthcare take over distributorship of Halyard feeding tubes in July 2017; (b) making use of Hooi Loo’s services in Healthcare; (c) making use of the Corporation’s Malaysian office premises; and (d) setting up and operating Prius and Primuz. The court also had to address whether any such claims were barred by time, and whether the Corporation’s conduct amounted to acquiescence.
Third, the court had to determine whether Healthcare committed the tort of passing off vis-à-vis the Corporation, and whether Healthcare should be held liable for dishonest and/or knowing assistance and/or receipt in equity. In parallel, the court had to decide whether Hooi Loo breached the terms of her employment contract, and whether defences of time bar and acquiescence applied to the claims against her. Finally, the court had to assess whether the pleaded conspiracy to defraud could be made out against all three defendants.
How Did the Court Analyse the Issues?
The court’s analysis proceeded by first setting out the parties’ competing narratives and then applying established principles governing fiduciary duties, employment contract obligations, and the tortious and equitable causes of action pleaded. A recurring analytical thread was the evidential burden on the Corporation to prove not only that the defendants acted in a way that was commercially competitive, but that the conduct amounted to a legal breach—particularly a breach of fiduciary duty—rather than conduct permitted by the parties’ agreed framework or by consent.
On fiduciary duties, the court examined the “ground rules” Henry and Phang allegedly agreed for managing opportunities. While directors owe duties of loyalty and must avoid conflicts, the court considered whether the parties’ arrangement affected the assessment of breach. Henry’s evidence suggested a mutual disclosure-and-offer mechanism: if an opportunity was disclosed and not accepted, each party could pursue it independently. Phang’s denial of certain disclosures (including Henry’s alleged intention to set up Absolmed) meant that the court had to weigh credibility and determine what was actually agreed and what was actually disclosed. The court’s approach indicates that the existence of an agreed framework, and the parties’ conduct in relation to it, can be relevant to whether a director’s conduct is inconsistent with fiduciary obligations.
The court also addressed the concept of acquiescence and limitation. The judgment headings show that the court considered acquiescence as a defence to equitable claims and also considered time bar issues, including references to s 391 of the Companies Act (as indicated in the headings). Although the provided extract does not reproduce the court’s detailed reasoning on each limitation point, the structure of the judgment suggests that the court treated limitation and acquiescence as potentially dispositive or at least as significant barriers to relief, particularly where the alleged breaches involved conduct that occurred years before suit.
In relation to the alleged diversion of business opportunities and competition through Healthcare, the court analysed whether the Corporation had established that the opportunities were “corporate” opportunities belonging to the Corporation, or whether they were opportunities that the director was free to pursue independently under the parties’ arrangement. The court also considered whether the Corporation’s knowledge of Healthcare’s activities undermined its ability to claim later that the director had acted secretly or in breach. The judgment headings refer to “Henry’s knowledge – and consent” and to “why Phang’s openness about Healthcare was important,” indicating that the court treated transparency and the Corporation’s awareness as relevant to the fiduciary breach inquiry and to equitable defences.
On the specific allegations—such as Healthcare taking over the Halyard feeding tubes distributorship in July 2017, the use of Hooi Loo’s services, and the alleged use of Malaysian office premises—the court would have had to determine whether these actions were undertaken in breach of duty, whether they were properly authorised, and whether the Corporation had consented or acquiesced. The headings also indicate that the court considered “self-dealing” and “fiduciary relationships—when arising,” suggesting that the court examined not only what Phang did, but also when and how fiduciary duties attached in the relevant circumstances.
For the employment-related claims, the court had to decide whether Hooi Loo breached her employment contract and whether the termination was without notice (as indicated by the headings). The analysis would have involved interpreting the employment terms, assessing whether the alleged conduct fell within contractual prohibitions, and considering whether defences of time bar and acquiescence applied. The court’s dismissal of the claims indicates that the Corporation did not prove the contractual breaches to the required standard, or that defences prevented recovery.
For tort and equitable claims, the court considered passing off and conspiracy to defraud. Passing off requires proof of goodwill, misrepresentation, and damage (or a likelihood of damage). The court’s dismissal suggests that the Corporation failed to establish the necessary elements, such as the existence of goodwill attributable to the Corporation in the relevant market, the likelihood of confusion, or the causal link to damage. For conspiracy to defraud, the court would have required proof of an agreement and unlawful means or dishonest intent. The dismissal indicates that the Corporation did not establish the requisite conspiracy elements against the defendants.
Finally, the court addressed equitable claims for knowing assistance and/or receipt, which typically require proof that a third party assisted in a breach of trust or fiduciary duty with knowledge (actual or constructive) and that the defendant’s conduct met the legal threshold for liability. The court’s dismissal indicates that the Corporation did not prove the underlying breach and/or did not prove the requisite knowledge or dishonesty on the part of Healthcare and/or Hooi Loo.
What Was the Outcome?
The High Court dismissed the Corporation’s claims against Phang, Healthcare, and Hooi Loo in both Suit No 793 of 2018 and Suit No 794 of 2018. The court’s reasons confirm that the Corporation failed to establish liability across the pleaded causes of action, including breach of fiduciary duty, breach of employment contract, passing off, conspiracy to defraud, and equitable claims for knowing assistance/receipt.
As the trial was not bifurcated, the dismissal had practical effect across both liability and damages: the Corporation received no monetary or injunctive relief arising from the suits. The judgment also addresses costs, meaning the court would have determined the appropriate costs consequences following the dismissal (the detailed costs order is not included in the provided extract).
Why Does This Case Matter?
This decision is significant for directors and corporate stakeholders because it illustrates how fiduciary duty claims in Singapore can turn on factual nuance—particularly where the parties’ relationship includes an alleged disclosure-and-consent framework. Even where a director is involved in a competing business, the court will scrutinise whether the conduct was actually disclosed, whether the corporation knew and accepted it, and whether the alleged opportunities were truly corporate opportunities rather than independent ventures permitted by agreement.
The case also demonstrates the importance of equitable defences such as acquiescence and the role of limitation. Where alleged breaches involve conduct over several years, plaintiffs must act promptly and must be able to explain why they did not seek earlier relief. For practitioners, this underscores the need to gather contemporaneous evidence of secrecy, lack of consent, and the corporation’s lack of knowledge, as well as to evaluate whether delay or tolerance undermines equitable remedies.
Finally, the judgment is useful for litigators because it covers a broad range of claims—fiduciary duty, employment contract, passing off, conspiracy, and knowing assistance/receipt—within a single factual dispute. The court’s dismissal across these categories suggests that a failure to prove the core wrongdoing (or the required mental element and evidential elements) can be fatal to multiple causes of action. Lawyers should therefore treat fiduciary and tort/equity claims as interdependent: the evidential foundation for one claim often determines the viability of others.
Legislation Referenced
- Companies Act (Singapore) — s 391 (as indicated in the judgment headings)
Cases Cited
- [2020] SGHC 268 (as provided in the metadata)
Source Documents
This article analyses [2020] SGHC 268 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.